As Managing Partner at Thia Ventures, Bart invests at the intersection of food, biotech and health. He has vast experience in biotech investing, having in the past established and led Droia Ventures, a global oncology-focused VC fund. Recognising the growing importance of biotech in transforming our food systems, he founded Thia with his ex-BCG colleague and former Louis Dreyfus Company CEO, Serge Schoen.
